Hipposcreen Neurotech (HNC) has introduced a stress electroencephalogram (EEG) evaluation device, a diagnostic tool that combines AI algorithms and brainwave sign amplifying circuits. It handiest takes the system ninety seconds to measure brainwave signals and generate scientific information that support medical doctors diagnose and treat depression, in line with the enterprise.
HNC, based by using a countrywide Taipei school of expertise (Taipei Tech) research group with funding from Compal, referred to that greater than 300 hundred million people in the world undergo from depression and fewer than half of them are receiving treatment. In some countries, no multiple tenth of the individuals with depression are getting scientific care.
HNC has been chosen with the aid of the Ministry of Science and technology (MOST) to be among the many teams so that you can existing their achievements at the Taiwan Tech arena (TTA) at CES 2020. it's hoped that HNC's participation at the adventure will aid it expand internationally and make it a pioneer leading Taiwan's foray into the AI-based mostly sensible diagnostics systems sector.
HNC's gadget aspects high usability, speedy measurement and excessive accuracy
The research crew led through Yi Hung Liu, a professor from Taipei Tech, that established HNC in April 2019, have engaged in the analyze of brainwave sign processing, AI algorithms and neuroscience analysis for greater than a decade.
Daniel Weng, HNC's CTO, pointed out the analysis of intellectual disorders, by and large depression, has all the time relied on the medical professional's professional knowledge and scientific journey, together with the use of the patient's self-evaluation reports. HNC's stress EEG evaluation gadget is aimed to enable doctors to make analysis in line with scientific measurements of brainwave signals and facts readings in order to allow early detection and medication.
HNC's stress EEG assessment gadget amplifies brainwave indicators measured through EEG, procedures the alerts and sends the effects to the cloud for evaluation. The system is convenient to operate, speedy and accurate so it could possibly proceed to commercialization ahead of the competition, Weng talked about.
Weng explained that HNC's equipment requires simple education techniques. The patient handiest needs to placed on a black electrode cap and sit down in front of the laptop. signals are accrued during the electrodes. After the affected person appears on the black pass on the screen for ninety seconds, an assessment report is generated to point out the stress stage with a coloured distribution chart. Darker hues characterize better stress tiers and the gap to the darkish color zone suggests the subject's chance of having depression.
"The equipment's sensible analysis achieves 80% accuracy, making it a positive scientific reference," spoke of Weng. The success is viable as a result of when they had been doing analysis at Taipei Tech, the crew had collaborated with national Taiwan school health facility and Harvard scientific college to compile EEG records from depressed patients and non-depressed people for computer studying. With the establishment and boom of HNC, they now partner with three main scientific associations in Taiwan for entry to EEG statistics, so one can aid further increase the accuracy and optimize the device, Weng talked about.
extend preventive medicine to mental fitness care
With Compal's guide in hardware, HNC stated it turned into in a position to finished the device aspect of its device in a short while. moreover, with Compal's neatly centered presence in the biomedical sector, HNC's device is expected to move defense certifications via the end of December 2019, making it the first brainwave instrument employer in Taiwan to attain scientific-grade certifications.
HNC plans to begin pilot operation of its first-generation stress EEG assessment equipment in the 2d half of 2020 and formally launch the gadget in 2021. It looks to market the equipment to hospitals and clinics in Taiwan in the first phase and faucet the actual examination sector in the 2nd part.
As part of its efforts to bring its product to market, HNC is also in the procedure of obtaining US FDA approval for clinical gadgets in an try and foray into international markets. aside from depression, HNC is also working on developing AI algorithms to aid medical doctors diagnose other brain-linked problems including dementia and a focus deficit hyperactivity disorder (ADHD) using scientific size tools. The intention is to make AI a crucial aid to scientific specialists in mental health screening and medication.
Compal is HNC's largest shareholder, having invested NT$42 million (US$1.4 million) to hang a 70% stake.
Weng expects HNC's participation at the TTA at CES 2020 to increase HNC's horizon, and produce opportunities for HNC to crew up with with foreign partners.
HNC CTO Daniel Weng demonstrates the way to function the enterprise's stress EEG assessment systemPhoto: Digitimes body of workers, December 2019
